Janux Therapeutics
JANX • NASDAQ • Stock Fundamentals
Janux Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO David Alan Campbell, with a market cap of $833.0M.
Market Cap$833.0M
Employees68.0
CEODavid Alan Campbell
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 7, 2026 · 1 month 7 days agoQ1 2026
View reportNext EarningsAug 6, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Janux Therapeutics FAQ
Common questions about Janux Therapeutics
Janux Therapeutics (JANX) has a market capitalization of $833.0M and trades on NASDAQ.
Janux Therapeutics has approximately 68 employees.